Paolo Farneti/LinkedIn
Aug 11, 2025, 01:43
Delphi Consensus: A Safe Guide to Use of Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-related Epistaxis
JAMA Otolaryngology – Head & Neck Surgery shared an insightful post on X:
”A Delphi consensus among six international experts established 30 statements to guide the safe and effective use of sclerotherapy for hereditary hemorrhagic telangiectasia (HHT)-related epistaxis.”
Read the full article here.
Article: Consensus on Sclerotherapy for Patients With Hereditary Hemorrhagic Telangiectasia–Related Epistaxis
Authors: Paolo Farneti, Sol Marcos-Salazar, Claudia Crocione,Holly Boyer, Roberto Puxeddu, Alan B. Whitehouse, Jay F. Piccirillo
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
-
Jan 9, 2026, 06:12James Caldwell on The Hidden Culprit in Perimesencephalic SAH